VGLUT2 may improve cognitive function in depressed rats by protecting prefrontal cortex neurons

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Depression is often linked to cognitive impairment, but the underlying mechanisms are not fully understood.
• Vesicular glutamate transporter 2 (VGLUT2) plays a crucial role in neurotransmission and neuronal health.

Purpose of the Study:

• To investigate the protective effects of fluoxetine on cognitive function and prefrontal cortex (PFC) neuronal integrity in a rat model of depression.
• To examine the role of VGLUT2 protein expression in depression-associated cognitive deficits and the therapeutic response to fluoxetine.

Main Methods:

• A rat model of depression-associated cognitive impairment was induced using chronic unpredictable mild stress (CUMS) and social isolation.
• Behavioral tests assessed mood, cognition, learning, and social behaviors.
• Histopathological examination of the PFC evaluated neuronal damage, apoptosis, and neuroplasticity, alongside VGLUT2 protein and mRNA levels.

Main Results:

• Rats exposed to CUMS and isolation showed depressive-like behaviors, impaired cognition, PFC neuronal damage, and reduced VGLUT2 expression.
• Fluoxetine treatment reversed these behavioral deficits, improved cognitive and social functions, and promoted neuronal repair in the PFC.
• VGLUT2 protein and mRNA levels were significantly increased following fluoxetine intervention, correlating with neuronal recovery.

Conclusions:

• CUMS combined with social isolation induces depression-like behaviors and cognitive impairment in rats, associated with PFC neuronal damage and decreased VGLUT2 expression.
• Fluoxetine intervention effectively ameliorated these impairments, suggesting a neuroprotective role.
• Restoration of VGLUT2 protein expression is linked to neuronal repair and behavioral recovery in depression-associated cognitive dysfunction.